Mirae Asset Global Investments Co. Ltd. Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mirae Asset Global Investments Co. Ltd. lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 27.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,749 shares of the medical device company's stock after purchasing an additional 4,916 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Cooper Companies were worth $2,097,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Fulton Bank N.A. raised its position in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after purchasing an additional 109 shares during the period. Mitchell & Pahl Private Wealth LLC raised its position in shares of Cooper Companies by 1.5% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock worth $881,000 after purchasing an additional 117 shares during the period. Bleakley Financial Group LLC raised its position in shares of Cooper Companies by 2.1% during the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock worth $636,000 after purchasing an additional 119 shares during the period. Mather Group LLC. raised its position in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after purchasing an additional 133 shares during the period. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after buying an additional 136 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Citigroup decreased their price target on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a report on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, Morgan Stanley decreased their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $117.00.

Cooper Companies Stock Performance

Shares of COO stock traded up $1.68 on Thursday, hitting $93.68. 1,037,848 shares of the stock were exchanged, compared to its average volume of 1,253,198. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $18.70 billion, a PE ratio of 48.04, a P/E/G ratio of 2.41 and a beta of 1.00. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The firm's 50 day moving average is $94.15 and its two-hundred day moving average is $99.76.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.87 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.